Thursday, August 6, 2020

COVID-19: No benefit of plasma therapy in reducing mortality risk, says AIIMS Director Dr Randeep Guleria

The therapy involves taking antibodies from the blood of a person who has recovered from COVID-19 and transfusing those into an active coronavirus infected patient to help kickstart the immune system to fight back the infection.

from Zee News :Zee News - Health https://ift.tt/3ifY17f
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

How India’s Love For Tea-Time Treats Is Raising Diabetes Risk?

Tea itself isn’t the problem it is the habitual pairing with high-sugar, high-salt, and high-fat snacks. With India witnessing rising diabet...